Alkem Laboratories Ltd share price logo

Alkem Share Price (ALKEM)

Check the latest share price of Alkem, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹4998.50.4%

as on 04:01PM, 18 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Alkem Stock Performance

Get live Alkem share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹4,969.8
    Day's Price Range
    ₹5,048
  • 52 Week's Low

    52 Week's High

    ₹4,491.65
    52-Week Price Range
    ₹6,439.9
1 Month Return+ 4.45 %
3 Month Return+ 0.37 %
1 Year Return-4.82 %
3 Year Return+ 54.42 %
5 Year Return+ 100.16 %
Previous Close₹5,018.70
Open₹5,048.00
Volume99.41K
Upper Circuit₹5,520.50
Lower Circuit₹4,516.90

Alkem Fundamentals & Key Indicators

Check Alkem market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹60,006.09 Cr

Return on Equity (ROE)

17.56

PE Ratio (TTM)

27.71

Return on capital employed (ROCE)

17.28

Industry PE ratio

48.9

Beta (LTM)

0.58

P/B Ratio

5.6

Dividend Yield

0.81

PEG Ratio

0.9

Quarterly Earnings Growth YOY

6.09

EPS (TTM)

151.52

Sector

Pharmaceuticals

Book Value

862.57

Technical Analysis

How to invest in Alkem?

Investing in Alkem is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Alkem or ALKEM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Alkem or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Alkem with just a few clicks!

Alkem Stock's Interest Amongst Investors

-33%

Period Jul 19, 2025 to Jun 19, 2025. Change in 30 Days vs previous period

Search interest for Alkem Laboratories Ltd Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Alkem Valuation

Track how Alkem P/E has moved over time to understand its valuation trends.

Alkem in the last 5 years

  • Overview

  • Trends

Lowest (20.07x)

March 24, 2021

Today (27.71x)

July 17, 2025

Industry (48.90x)

July 17, 2025

Highest (44.21x)

August 9, 2023

LowHigh

Today’s Price to Earnings Ratio: 27.71x

Alkem Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Alkem.

based on 21 analysts

HOLD

42.86%

Buy

19.05%

Hold

38.10%

Sell

42.86% of analysts recommend a 'HOLD' rating for Alkem. Average target price of ₹5179.67

Source: S&P Global Market Intelligence

Alkem Share Price Target

Get share price movements and forecasts by analysts on Alkem.

Alkem price forecast by 21 analysts

Upside of3.21%

High

₹6684

Target

₹5179.67

Low

₹4030

Alkem target price ₹5179.67, a slight upside of 3.21% compared to current price of ₹4998.5. According to 21 analysts rating.

Source: S&P Global Market Intelligence

Alkem Financial Results

Get the annual and quarterly financial summary of Alkem, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

2936 (0%)3032 (3%)3415 (13%)3374 (1%)3144 (7%)
Net Income

(in ₹ Cr)

304 (0%)550 (81%)702 (28%)641 (9%)323 (50%)
Net Profit Margin10.37% (0%)18.15% (75%)20.56% (13%)18.99% (8%)10.27% (46%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

10962 (0%)13369 (22%)12939 (3%)14291 (10%)
Total Liabilities

(in ₹ Cr)

3336 (0%)4625 (39%)3589 (22%)3737 (4%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

682 (0%)1324 (94%)1299 (2%)1437 (11%)1687 (17%)

Indices Featuring Alkem Stock

Check stock indices that include Alkem.

Nifty Midcap 100

₹59,104.50

-0.7 (-414.6%)

BSE 200

₹11,383.68

-0.59 (-67.99%)

S&P BSE 400 MidSmallCap

₹12,354.47

-0.66 (-81.66%)

Nifty MidSmallcap 400

₹20,473.85

-0.67 (-139%)

Nifty Midcap 150

₹21,858.85

-0.67 (-147.4%)

Nifty Healthcare

₹14,668.30

-0.65 (-95.6%)

BSE Mid-Cap

₹46,775.77

-0.62 (-290.23%)

S&P BSE 150 MidCap

₹16,236.56

-0.67 (-109.38%)

NIFTY PHARMA

₹22,592.75

-0.39 (-87.6%)

BSE Healthcare

₹45,128.54

-0.62 (-281.3%)

Nifty 200

₹13,993.45

-0.61 (-86.1%)

Nifty 500

₹23,275.15

-0.62 (-144.55%)

Nifty Midcap 50

₹16,645.40

-0.61 (-102.05%)

S&P BSE 250 LargeMidCap

₹10,808.95

-0.6 (-64.77%)

BSE 500

₹36,532.54

-0.6 (-220.41%)

Nifty LargeMidcap 250

₹16,359.95

-0.63 (-104.05%)

Alkem Earnings and Dividends

View detailed summary of the earnings and dividend history of Alkem.

  • Alkem Laboratories Ltd Earnings Results

    Alkem Laboratories Ltd’s net profit jumped 4.19% since last year same period to ₹305.86Cr in the Q4 2024-2025. On a quarterly growth basis, Alkem Laboratories Ltd has generated -51.13% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Alkem Laboratories Ltd Dividends February,2025

    In the quarter ending December 2024, Alkem Laboratories Ltd has declared dividend of ₹37.00 - translating a dividend yield of 1.53%.

    Read More about Dividends

Alkem Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Alkem.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
55.13%
0.00
Foreign Institutions
9.41%
0.00
Mutual Funds
14.97%
0.00
Retail Investors
16.05%
0.00
Others
4.45%
0.00

Alkem vs Peers

Compare market cap, revenue, PE, and other key metrics of Alkem with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
HOLD60,006.0920.03%0.561,81112,667
HOLD24,984.3711.04%0.534922,461
HOLD44,325.64105.99%0.693545,553
BUY10,741.5913.74%0.64119547
BUY6,153.4518.47%0.5390687

Alkem News & Key Events

Latest news and events in one place to help you make informed investing decisions in Alkem.

  • Alkem Laboratories Marks Fifth Straight Session Gain - 17 Jul, 2025

    Alkem Laboratories Ltd has gained 0.34% today, reaching Rs 5019, marking its fifth consecutive session of increases. Despite this, the stock is down 4.81% over the past year.

Insights on Alkem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ALKEM stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.01% to 14.97% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 132.7% return, outperforming this stock by 78.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 48.1% return, outperforming this stock by 52.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.54K Cr → 3.28K Cr (in ₹), with an average decrease of 3.7% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 16.18% to 16.05% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 10.15% to 9.41% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 688.64 Cr → 305.86 Cr (in ₹), with an average decrease of 30.1% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 55.66% to 55.13% in Mar 2025 quarter

About Alkem

Alkem Laboratories Ltd is a leading pharmaceutical company founded in 1973 by Mr. Samir C. Desai.

With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.

Revenue: ₹3,143.75Cr as on March 2025 (Q4 FY25)
Net Profit: ₹323.01Cr as on March 2025 (Q4 FY25)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
OrganisationAlkem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOBasudeo N Singh
E-voting on sharesClick here to vote

FAQs

What is Alkem share price today?

Alkem share price today stands at ₹4998.5, Open: ₹5048, Previous Close: ₹5018.7, High: ₹5048, Low: ₹4969.8, 52 Week High: ₹6439.9, 52 Week Low: ₹4491.65.

What is today's traded volume of Alkem?

Today's traded volume of Alkem is 99.41K. Which means that 99.41K shares of Alkem were bought and sold on the stock market during today's trading session.

What is Alkem's market cap today?

Today's market capitalisation of Alkem is ₹60,006.09 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Alkem?

Alkem’s 52 week high is ₹6439.9 and 52 week low is ₹4491.65. The current share price of Alkem is ₹4998.5, which is -22.38% down from its 52 week high and 11.28% up from its 52 week low.